Theme and Speakers:

• A Paradigm Change in Diagnostics - Kevin Dhaliwal, University of Edinburgh
• Photonic diagnostics for healthcare applications - Robert Thomson, Heriot-Watt University
• A multiomics approach to next generation diagnostics - Clare Trippett, CPI

-

Speaker biographies

• Kev Dhaliwal is a Professor of Molecular Imaging and Healthcare Technology at the University of Edinburgh and a Consultant Physician in Respiratory Medicine. He has a passion for developing new technologies for healthcare impact and is the Chief Investigator on six first-in-human trials of optical molecular imaging reagents and devices related to the diagnosis of bacterial infection, inflammation and cancer. Collaborating widely with industry, he is an advocate of the need to work across scientific disciplines and translate physical science research into healthcare.

• Robert R. Thomson obtained the B.Sc in Physics from Heriot Watt University in 2000, the M.Sc in Optoelectronics and Laser Devices from the University of St Andrews in 2001, and the Ph.D in Physics from Heriot Watt University in 2006. From 2010-15 he was an STFC Advanced Fellow, developing photonic technologies for applications in astronomy. He is currently Full Professor of Photonics at the Institute of Photonics and Quantum Sciences (IPaQS) at Heriot Watt University in Edinburgh, Scotland, where he leads the photonic instrumentation group (hi.eps.hw.ac.uk). He has published over 100 articles in leading journals such as Adv. Opt. Photon., Phys. Rev. Lett., and Nat. Commun. and has received grants valued at >£34M (£10M as PI). His research interests range from fundamental optics to highly applied photonics in areas such as ultrafast laser micro-fabrication and biomedical photonics (see u-care.ac.uk). He co-founded Optoscribe Ltd in 2010, which was acquired by Intel in 2022.

• Clare Trippett is the Principal Strategic Opportunities Manager for health and life sciences at CPI, one of the UK’s High Value Manufacturing Catapult centres and a pioneering social enterprise that accelerates the development, scale-up and commercialisation of deep tech and sustainable manufacturing solutions. Clare holds a PhD in microbiome science from Newcastle University and has worked in the biopharma, biotechnology and bioprocessing industry for circa 20 years across a number of technically focused and strategic roles. In her current role at CPI Clare is responsible for exploring, identifying, and developing large scale opportunities to support long term strategic growth and impact generation.

-

The Explore: HealthTech webinar series offers an opportunity for companies across sectors to access the latest research and expertise at the University of Edinburgh in collaboration with Heriot-Watt University, CPI, and the Medical Device Manufacturing Centre. 

-

To book, "Register as a Guest" or use a University of Edinburgh login. For assistance, please contact us on eievents@ei.ed.ac.uk